Free Trial
The Rate Lock Ends Tonight! MarketBeat All Access Returns to $249
  • 0Days
  • 0Hours
  • 0Minutes
  • 0Seconds
Save $100 a Year
Claim MarketBeat All Access Sale Promotion
NYSE:VATE

INNOVATE Q3 2026 Earnings Date & Estimates

INNOVATE logo
$5.55 -0.25 (-4.31%)
Closing price 03:59 PM Eastern
Extended Trading
$5.52 -0.03 (-0.54%)
As of 05:08 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

INNOVATE is estimated to report Q3 2026 earnings on Thursday, November 12, 2026, after market closes. The conference call is scheduled for November 11, 2026 at 4:30 PM ET.

Upcoming Earnings Announcement

Quarter
Q3 2026
Announcement Date
Time
After Market Closes
Conference Call Date
Conference Call
4:30 PM ET

What Analysts Expect from INNOVATE in Q3 2026

INNOVATE is expected to post earnings of -$2.1843 per share on revenue of $251.70 million. In the same quarter a year earlier INNOVATE reported -$0.71 per share on revenue of $347.10 million. INNOVATE last reported on August 6, 2026, posting $0.71 per share and beating the -$2.1843 consensus estimate.

Consensus Estimates

Consensus EPS
-$2.1843
Expected Revenue
$251.70 million
Prior-Year EPS
-$0.71
Prior-Year Revenue
$347.10 million
Expected Revenue Growth
-27.5%

Recent Track Record

Last Reported
Q2 2026
Last Quarter EPS
$0.71 (Beat by +$2.8943)
Last Quarter Revenue
$421.60 million

INNOVATE Q3 2026 Earnings FAQ

INNOVATE (NYSE:VATE) is estimated to report Q3 2026 earnings on Thursday, November 12, 2026, after market closes. This date is estimated from past reporting schedules and may change once the company confirms it.

INNOVATE's Q3 2026 earnings conference call is scheduled for Wednesday, November 11, 2026 at 4:30 PM ET. MarketBeat streams the conference call audio and posts the transcript as soon as possible on the earnings announcement date.

Analysts expect INNOVATE to post earnings of -$2.1843 per share for Q3 2026.

The consensus revenue estimate for INNOVATE is $251.70 million for Q3 2026.

INNOVATE Earnings Headlines

The Iran War Isn’t Chaos. It’s Strategy.
Two thousand missiles struck Iran. Three days later, Dylan Jovine sat in two private meetings with U.S. Congressmen no cameras, no staff. What he found afterward points to a coordinated Two-Front Economic War already in motion, according to his research at Behind the Markets.tc pixel
INNOVATE Completes Sale of DBM Global to IES Holdings
See More INNOVATE Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like INNOVATE? Sign up for Earnings360's daily newsletter to receive timely earnings updates on INNOVATE and other key companies, straight to your email.

About INNOVATE

INNOVATE (NYSE:VATE) (NYSE: VATE) is a diversified holding company focused primarily on infrastructure and life sciences businesses. Through its subsidiaries, the company operates businesses involved in structural steel fabrication, industrial construction, engineering and related infrastructure services, as well as the development and commercialization of medical technologies.

Its infrastructure operations are centered on DBM Global, a provider of structural steel and related services for commercial, industrial, institutional and infrastructure projects. DBM Global’s capabilities include steel fabrication and erection, detailing, construction management and project services, supporting projects in the United States and other markets.

INNOVATE’s life sciences activities are conducted through Pansend Life Sciences and its portfolio companies. These businesses have focused on medical devices, dermatology and other healthcare technologies, including products designed for aesthetic and therapeutic applications. The company was formerly known as HC2 Holdings and adopted the INNOVATE name in 2021 as part of its evolution into a diversified holding company.

View INNOVATE Profile